vs
Side-by-side financial comparison of Dexcom (DXCM) and MERCURY GENERAL CORP (MCY). Click either name above to swap in a different company.
MERCURY GENERAL CORP is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.2× Dexcom). Dexcom runs the higher net margin — 21.2% vs 13.2%, a 8.0% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 12.4%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 9.8%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Mercury General Corporation is a multiple-line insurance organization that offers personal automobiles, homeowners, renters, and business insurance. Mercury's primary focus is automobiles and homeowners' insurance.
DXCM vs MCY — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $1.3B | $1.5B |
| Net Profit | $267.3M | $202.5M |
| Gross Margin | 62.9% | 99.7% |
| Operating Margin | 25.6% | 16.2% |
| Net Margin | 21.2% | 13.2% |
| Revenue YoY | 21.6% | 12.4% |
| Net Profit YoY | 153.6% | 100.4% |
| EPS (diluted) | $0.67 | $3.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.2B | $1.6B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.0B | $1.4B | ||
| Q4 24 | $1.1B | $1.4B | ||
| Q3 24 | $994.2M | $1.5B | ||
| Q2 24 | $1.0B | $1.3B |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $202.5M | ||
| Q3 25 | $283.8M | $280.4M | ||
| Q2 25 | $179.8M | $166.5M | ||
| Q1 25 | $105.4M | $-108.3M | ||
| Q4 24 | $151.7M | $101.1M | ||
| Q3 24 | $134.6M | $230.9M | ||
| Q2 24 | $143.5M | $62.6M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | 99.7% | ||
| Q3 25 | 60.5% | 99.8% | ||
| Q2 25 | 59.5% | 99.8% | ||
| Q1 25 | 56.9% | 99.7% | ||
| Q4 24 | 58.9% | 99.7% | ||
| Q3 24 | 59.7% | 99.8% | ||
| Q2 24 | 62.4% | 99.8% |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 16.2% | ||
| Q3 25 | 20.1% | 22.1% | ||
| Q2 25 | 18.4% | 14.0% | ||
| Q1 25 | 12.9% | -10.2% | ||
| Q4 24 | 17.0% | 9.0% | ||
| Q3 24 | 15.3% | 18.8% | ||
| Q2 24 | 15.7% | 5.8% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 13.2% | ||
| Q3 25 | 23.5% | 17.7% | ||
| Q2 25 | 15.5% | 11.3% | ||
| Q1 25 | 10.2% | -7.8% | ||
| Q4 24 | 13.6% | 7.4% | ||
| Q3 24 | 13.5% | 15.1% | ||
| Q2 24 | 14.3% | 4.8% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $3.66 | ||
| Q3 25 | $0.70 | $5.06 | ||
| Q2 25 | $0.45 | $3.01 | ||
| Q1 25 | $0.27 | $-1.96 | ||
| Q4 24 | $0.37 | $1.82 | ||
| Q3 24 | $0.34 | $4.17 | ||
| Q2 24 | $0.35 | $1.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | $575.0M |
| Stockholders' EquityBook value | $2.7B | $2.4B |
| Total Assets | $6.3B | $9.6B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $575.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $575.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.4B | ||
| Q3 25 | $2.7B | $2.2B | ||
| Q2 25 | $2.6B | $2.0B | ||
| Q1 25 | $2.3B | $1.8B | ||
| Q4 24 | $2.1B | $1.9B | ||
| Q3 24 | $2.0B | $1.9B | ||
| Q2 24 | $2.4B | $1.6B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $9.6B | ||
| Q3 25 | $7.5B | $9.4B | ||
| Q2 25 | $7.3B | $9.1B | ||
| Q1 25 | $6.8B | $9.0B | ||
| Q4 24 | $6.5B | $8.3B | ||
| Q3 24 | $6.4B | $8.2B | ||
| Q2 24 | $6.8B | $7.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | — | $287.9M |
| Free Cash FlowOCF − Capex | — | $273.9M |
| FCF MarginFCF / Revenue | — | 17.8% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | — | 1.42× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.0B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $287.9M | ||
| Q3 25 | $659.9M | $496.4M | ||
| Q2 25 | $303.0M | $371.6M | ||
| Q1 25 | $183.8M | $-68.7M | ||
| Q4 24 | $301.4M | $248.3M | ||
| Q3 24 | $199.5M | $318.1M | ||
| Q2 24 | $279.4M | $278.0M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $273.9M | ||
| Q3 25 | $579.4M | $479.5M | ||
| Q2 25 | $208.9M | $357.2M | ||
| Q1 25 | $96.8M | $-81.9M | ||
| Q4 24 | $176.8M | $236.0M | ||
| Q3 24 | $88.3M | $306.2M | ||
| Q2 24 | $213.3M | $266.5M |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 17.8% | ||
| Q3 25 | 47.9% | 30.3% | ||
| Q2 25 | 18.1% | 24.2% | ||
| Q1 25 | 9.3% | -5.9% | ||
| Q4 24 | 15.9% | 17.3% | ||
| Q3 24 | 8.9% | 20.0% | ||
| Q2 24 | 21.2% | 20.4% |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 0.9% | ||
| Q3 25 | 6.7% | 1.1% | ||
| Q2 25 | 8.1% | 1.0% | ||
| Q1 25 | 8.4% | 0.9% | ||
| Q4 24 | 11.2% | 0.9% | ||
| Q3 24 | 11.2% | 0.8% | ||
| Q2 24 | 6.6% | 0.9% |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.42× | ||
| Q3 25 | 2.33× | 1.77× | ||
| Q2 25 | 1.69× | 2.23× | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 1.99× | 2.46× | ||
| Q3 24 | 1.48× | 1.38× | ||
| Q2 24 | 1.95× | 4.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.